Intervention to Reduce Serious Mental Illness and Suicide Stigma Among Medical Students
NCT ID: NCT05325320
Last Updated: 2022-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
126 participants
INTERVENTIONAL
2022-04-06
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Engaging Suicidal Patients in Mental Health Treatment
NCT05021224
Evaluation of a Brief, Scalable Module to Mitigate Suicidal Ideation Among Youth
NCT06586645
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
NCT05537376
Just-in-time Interventions for Reducing Short-term Suicide Risk
NCT05793541
Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago
NCT07125144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The proposed study aims to: 1) develop the content of an intervention to reduce SMI/SIA stigma among medical students, 2) determine the acceptability and feasibility of implementing the intervention among medical students by examining recruitment/screening procedures, participation/refusal/retention rates, and participant satisfaction, and; 3) pilot test the preliminary efficacy of the intervention in reducing SMI/SIA stigma among medical students by increasing knowledge of SMI and SIA, reducing negative attitudes towards SMI/SIA and increasing behavioral skills for providing healthcare to PSMI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stigma Reduction Intervention
Participants randomized to the experimental condition will receive the SMI/SIA Stigma Reduction Intervention.
SMI/SIA Stigma Reduction Intervention
Online course designed to reduce stigma behaviors towards serious mental illness and suicide ideation and attempt among medical students. It aims to improve medical students' healthcare delivery skills.
Disaster Preparedness Course
Participants randomized to the control condition will receive a Disaster Preparedness Course, addressing the basics of natural disaster preparedness.
Disaster Preparedness Course
Online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMI/SIA Stigma Reduction Intervention
Online course designed to reduce stigma behaviors towards serious mental illness and suicide ideation and attempt among medical students. It aims to improve medical students' healthcare delivery skills.
Disaster Preparedness Course
Online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Ponce Medical School Foundation, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eliut Rivera-Segarra, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Ponce Health Sciences University
Nelson Varas-Diaz, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Florida International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Florida International University
Miami, Florida, United States
Ponce Health Sciences University
Ponce, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nelson Varas Díaz, Ph.D
Role: primary
Eliut Rivera Segarra, Ph.D
Role: primary
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.